Recombinant Human CD83 Protein, MYC/DDK-tagged
Cat.No. : | CD83-3106H |
Product Overview : | Recombinant Human CD83 protein, fused to MYC/DDK-tagged at C-terminus, was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
- Download
Description : | The protein encoded by this gene is a single-pass type I membrane protein and member of the immunoglobulin superfamily of receptors. The encoded protein may be involved in the regulation of antigen presentation. A soluble form of this protein can bind to dendritic cells and inhibit their maturation. Three transcript variants encoding different isoforms have been found for this gene. |
Source : | HEK293 |
Species : | Human |
Tag : | Myc&DDK |
Form : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol. |
Molecular Mass : | 22.9 kDa |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Concentration : | >50 ug/mL as determined by microplate BCA method |
Gene Name : | CD83 CD83 molecule [ Homo sapiens ] |
Official Symbol : | CD83 |
Synonyms : | BL11; HB15 |
Gene ID : | 9308 |
mRNA Refseq : | NM_001040280 |
Protein Refseq : | NP_001035370 |
MIM : | 604534 |
UniProt ID : | Q01151 |
Products Types
◆ Recombinant Protein | ||
CD83-577R | Recombinant Rhesus Macaque CD83 Protein, His (Fc)-Avi-tagged | +Inquiry |
Cd83-850M | Recombinant Mouse Cd83 Protein, MYC/DDK-tagged | +Inquiry |
CD83-1505C | Recombinant Cynomolgus CD83 protein, His-tagged | +Inquiry |
CD83-751R | Recombinant Cynomolgus/Rhesus CD83 protein(Met1-Ala143), His-tagged | +Inquiry |
Cd83-702R | Recombinant Rat Cd83 Protein, His-tagged | +Inquiry |
◆ Lysates | ||
CD83-2095HCL | Recombinant Human CD83 cell lysate | +Inquiry |
CD83-1130CCL | Recombinant Cynomolgus CD83 cell lysate | +Inquiry |
CD83-1845MCL | Recombinant Mouse CD83 cell lysate | +Inquiry |
Related Gene
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewThe experimental conditions are wide, and the experimental results are accurate and reproducible.
The resulting strips are clear and bright, which greatly exceeds the expected results.
CD83 activity is maintained for a very long time and can be maintained for a long time, which is very stable and reliable.
Q&As (6)
Ask a questionYes, CD83 can be targeted as immunotherapy. Immunotherapy for CD83 has been explored in several clinical trials with some efficacy.
It is unclear whether there is a population difference in CD83 treatment. However, due to factors such as individual differences and genetic polymorphisms, different populations may respond differently to treatment. Therefore, population-specific treatment strategies may need to be individually adapted and optimized.
Future research on CD83 may involve more in-depth molecular mechanism studies, optimization and improvement of CD83-based immunotherapy strategies, and research on combination with other immunotherapies or drugs.
CD83 interacts and regulates with other immune checkpoint molecules. Together, they are involved in the regulation of the immune response.
Yes, CD83 expression is regulated by a variety of molecules, including cytokines, transcription factors, and epigenetic modifications.
Current treatments for CD83 mainly include immunotherapy and gene therapy. Immunotherapy against CD83 works primarily by modulating the function of dendritic cells and T cells.
Ask a Question for All CD83 Products
Required fields are marked with *
My Review for All CD83 Products
Required fields are marked with *
Inquiry Basket